|
Analysis of Abbott Laboratories Antitrust Litigation
Attorneys Hollis L. Salzman and Michael W. Stocker authored an article regarding the In re Abbott Laboratories Antitrust Litigation in the June 20, 2008 issue of the BNA's Pharmaceutical Law & Industry Report.
June 20, 2008
|
|
US Focus: Time for action
Attorneys Thomas A. Dubbs and Alan I. Ellman authored an article regarding the role of UK and European investors in US class actions in the April 17, 2008 issue of the UK's Legal Week.
April 17, 2008
|
|
|
|
|
|
The Advantages of Not Opting Out of Class Action Litigation
Attorneys Bernard Persky and Gregory Asciolla authored an article entitled "The Advantages of Not Opting Out of Class Action Litigation." The article ran in the Corporate Counseling Committee's latest edition of its newsletter, The Antitrust Counselor.
February 01, 2008
|
|
Corporate Fraud Is Not Constructed By Plaintiffs' Bar
Partner Bernard Persky authored an article in Competition Law 360 in response to an article entitled "State Attorney General Class Actions Raise Concerns" which launched a wide-ranging attack on the role of private counsel in government enforcement actions.
October 15, 2007
|
|
|
|
'Tellabs': PSLRA Pleading Test Comparative, Not Absolute
Attorneys Christopher J. Keller and Michael W. Stocker authored an article in the New York Law Journal entitled "Tellabs: PSLRA Pleading Test Comparative, Not Absolute" regarding securities plaintiffs' pleadings and how they will be affected by the U.S. Supreme Court's decision in the Tellabs v. Makor Issues & Rights Ltd case.
October 03, 2007
|
|
|
|
|
|
Confidential Informants in Private Litigation
Associate Ethan D. Wohl published an article on the use of confidential informants in private securities litigation, entitled "Confidential Informants in Private Litigation: Balancing Interests in Anonymity and Disclosure" in the Fordham Journal of Corporate & Financial Law.
May 01, 2007
|
|
When Does a Company Intend to Lie?
Associate Ethan D. Wohl published an article addressing the standard for imputing intent to corporations, entitled "When Does a Company Intend to Lie?" in the Andrews Securities Litigation & Regulation Reporter.
April 04, 2007
|
|
|
|
|
|
|
|
|
|
|
|
44th Street Notes
Edward Labaton commented in the March 2005 issue of 44th Street Notes, The Association of the Bar of the City of New York, "Plan Your Retirement: Senior Lawyers Committee Offers Ageless Advice."
March 01, 2005
|
|
|
|
|
|
|
|
|
|
Cipro Maker Fighting Antitrust Suits
Bayer accused of illegal deal to suppress generics
(Originally published in The National Law Journal)
This article reviews the recent history of litigation involving Bayer and the anti-anthrax prescription drug, Cipro.
October 23, 2001
|
|
|
